|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Magenta Therapeutics (NASDAQ: MGTA) through any online brokerage.
The latest price target for Magenta Therapeutics (NASDAQ: MGTA) was reported by Cantor Fitzgerald on June 29, 2021. The analyst firm set a price target for 20.00 expecting MGTA to rise to within 12 months (a possible 170.27% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Magenta Therapeutics (NASDAQ: MGTA) is $7.4 last updated Fri Jul 23 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Magenta Therapeutics.
There is no upcoming split for Magenta Therapeutics.
Magenta Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.